BREEDLOVE ROBERT CHARLES (Principal Accounting Officer) reported 1 transaction at PHATHOM PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 12/19/2025ACC: 0001193125-25-327135
Officer· Principal Accounting Officer
Since Feb 2026
-230.00
Net shares
Net seller
$3.7K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
230.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−230.00
Price / share
$16.28
Trade value
$3.74K
% of position
0.5%
12/18/2025
48.07K→47.84K
Total
Net shares
−230.00
Net value
-$3.74K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/18/2025 | F · Tax Withholding | −230.00 | $16.28 | $3.74K | 0.5% | 48.07K | 47.84K |
| Total | −230.00 | -$3.74K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned6.95K
Total
6.95K indirect6.95K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 6.95K | Indirect |
| Total | 6.95K | 6.95K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported